Though nominally classified as a diagnosis of exclusion (thus "triple-negative"), TNBC tumors frequently (72-75%) [5] overexpress epidermal growth factor receptor (EGFR), whereas only a minority (16%) of ER-positive breast cancers overexpress EGFR [5,6]. This evidence concerns the gene ESR1 and breast cancer.